Patterns of chemotherapy administration in high-risk soft tissue sarcoma and impact on overall survival

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 13, Issue 11, 2015, Pages 1366-1374

  Movva, Sujana ^a   Von Mehren, Margaret ^a   Ross, Eric A ^a   Handorf, Elizabeth ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ANGIOSARCOMA; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; EMBRYONAL CARCINOMA; EPITHELIOID SARCOMA; FEMALE; FIBROSARCOMA; GIANT CELL CARCINOMA; HIGH RISK PATIENT; HISTOLOGY; HUMAN; KAPLAN MEIER METHOD; LEIOMYOSARCOMA; LIPOSARCOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; MYOSARCOMA; MYXOSARCOMA; OVERALL SURVIVAL; PROPORTIONAL HAZARDS MODEL; RHABDOMYOSARCOMA; SMALL CELL SARCOMA; SOFT TISSUE SARCOMA; SPINDLE CELL SARCOMA; SYNOVIAL SARCOMA; UNDIFFERENTIATED CARCINOMA; AGED; COMORBIDITY; FACTUAL DATABASE; HEALTH SURVEY; MIDDLE AGED; MORTALITY; SARCOMA; SOCIOECONOMICS; TREATMENT OUTCOME; UNITED STATES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMORBIDITY; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; SARCOMA; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84947242587     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2015.0165     Document Type: Article

References (20)

1. Edge SB BD, Compton CC, Fritz AG, et al, eds. American Joint Committee on Cancer Staging Manual, 7th ed. New York, NY: Springer; 2010.
2. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration. Lancet 1997;350:1647-1654.
3. Pervaiz N, Colterjohn N, Farrokhyar F, et al. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer 2008;113:573-581.
4. Bilimoria KY, Stewart AK, Winchester DP, Ko CY. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol 2008;15:683-690.
5. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
6. Rosenbaum PR, Rubin DB. The Central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41-55.
7. Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 2011;46:399-424.
8. Xu S, Ross C, Raebel MA, et al. Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals. Value Health 2010;13:273-277.
9. Xie J, Liu C. Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data. Stat Med 2005;24:3089-3110.
10. Davison A, Hinkley DV. Bootstrap Methods and Their Application. New York, NY: Cambridge University Press; 1997.
11. Jones RL, Fisher C, Al-Muderis O, Judson IR. Differential sensitivity of liposarcoma subtypes to chemotherapy. Eur J Cancer 2005;41:2853-2860.
12. Zagars GK, Ballo MT, Pisters PW, et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer 2003;97:2530-2543.
13. Coindre JM, Terrier P, Guillou L, et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer 2001;91:1914-1926.
14. Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol 2002;20:791-796.
15. Frustaci S, Gherlinzoni F, De Paoli A, et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol 2001;19:1238-1247.
16. Frustaci S, De Paoli A, Bidoli E, et al. Ifosfamide in the adjuvant therapy of soft tissue sarcomas. Oncology 2003;65(Suppl 2):80-84.
17. Canter RJ, Qin LX, Maki RG, et al. A synovial sarcoma-specific preoperative nomogram supports a survival benefit to ifosfamide-based chemotherapy and improves risk stratification for patients. Clinical Can Res 2008;14:8191-8197.
18. Eilber FC, Brennan MF, Eilber FR, et al. Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma. Ann Surg 2007;246:105-113.
19. Eilber FC, Eilber FR, Eckardt J, et al. The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma. Ann Surg 2004;240:686-695; discussion 695-697.
20. Cormier JN, Huang X, Xing Y, et al. Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy-associated outcomes. J Clin Oncol 2004;22:4567-4574.